1 |
Risk factors associated with default among new smear positive TB patients treated under DOTS in India. |
|
| |
Vijay S, Kumar P, Chauhan LS, Vollepore BH, Kizhakkethil UP, Rao SG |
| PLoS One. 2010 ;5(4):e10043. |
|
|
|
2 |
Schwannoma of the ascending colon. |
|
| |
Mysorekar VV, Rao SG, Jalihal U, Sridhar M |
| Indian J Pathol Microbiol. 2010 Jan-Mar ;53(1):198-200. |
|
|
|
3 |
Characterization of novel beta-galactosidase activity that contributes to glycoprotein degradation and virulence in Streptococcus pneumoniae. |
|
| |
Terra VS, Homer KA, Rao SG, Andrew PW, Yesilkaya H |
| Infect Immun. 2010 Jan;78(1):348-57. |
|
|
|
4 |
Sirenomelia. |
|
| |
Gouri MS, Kumari KM, Rao SG, Devi U |
| Indian J Pathol Microbiol. 2009 Oct-Dec ;52(4):579-80. |
|
|
|
5 |
Intraventricular hydatid cyst in a child. |
|
| |
Kamath SM, Mysorekar VV, Rao SG, Varma RG |
| Indian J Pathol Microbiol. 2009 Oct-Dec ;52(4):571-2. |
|
|
|
6 |
Current progress in the pharmacological therapy of fibromyalgia. |
|
| |
Rao SG |
| Expert Opin Investig Drugs. 2009 Oct;18(10):1479-93. |
|
|
|
7 |
Regulation of extracellular matrix genes by arecoline in primary gingival fibroblasts requires epithelial factors. |
|
| |
Thangjam GS, Agarwal P, Balapure AK, Rao SG, Kondaiah P |
| J Periodontal Res. 2009 Dec;44(6):736-43. |
|
|
|
8 |
Transglutaminase-2 regulation by arecoline in gingival fibroblasts. |
|
| |
Thangjam GS, Agarwal P, Khan I, Verma UP, Balapure AK, Rao SG, Kondaiah P |
| J Dent Res. 2009 Feb;88(2):170-5. |
|
|
|
9 |
The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. |
|
| |
Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, Palmer RH |
| J Rheumatol. 2009 Feb;36(2):398-409. |
|
|
|
10 |
New spectrophotometric method for the determination of some drugs with iodine and wool fast blue BL. |
|
| |
Sastry CS, Rao SG, Y Naidu P, Srinivas KR |
| Talanta. 1998 Apr;45(6):1227-34. |
|
|
|
|
|
| Next >> |